MSB 6.10% $1.00 mesoblast limited

prochymal.. pre.15 months .., page-2

  1. 85 Posts.

    And important crucial 15 months (or thereabouts)ahead.

    MSB will need revenue on the horizon within the next 2 years, or they will need to do a cap raising or partnering or rationalise indications. They won't want to have 6 stage 3s ongoing with less than a year of cash let with no recurring income locked in. Hold on to your hats.

    I believe it was $310m at June at a current operational burn rate of $70m PA. This Osiris deal is $53m AUD cash, plus potentially another $50 but could be in stock rather than cash. Under new structure operation cash burn expected to incease by 15%, gets us to $80m burn per year but to be conservation assume it increases to $85m PA, so

    June 2013 $311m
    Osiris cash ($53m) (assume rest paid in stock)
    2014 burn ($85m)
    2015 burn ($85m)
    2016 burn ($85m)
    Bal approx $3m.

    I've excluded interest income on cash, but bound to be incremental corporate costs to offset this.

    Still pretty strong position, gives 3 years worst case and partner op could be best mitigation. Keep the cash coming in and gobble up all the talent and resources.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.00
Change
-0.065(6.10%)
Mkt cap ! $1.141B
Open High Low Value Volume
$1.04 $1.04 99.5¢ $2.638M 2.601M

Buyers (Bids)

No. Vol. Price($)
27 174994 99.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 15634 12
View Market Depth
Last trade - 14.01pm 04/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.